Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
The benchmark Nifty is likely to march towards 19,300-19,500 levels in coming days, as long as it holds the 19,000 mark, which is an immediate support, then 18,800 levels, experts said
Cochin Shipyard has witnessed a primary trend-line breakout on the weekly chart with strong volume followed by a breakout of Bullish Flag formation.
The Nifty Midcap and Smallcap indices rallied nearly 7 percent and 10 percent in March, and since February 19, both indices surged 11 percent and 15 percent respectively.
Vesuvius India shares rallied 4.25 percent intraday to touch fresh 52-week high of Rs 1,090 on Tuesday. CNBC-TV18's Varinder Bansal explained reasons for the rally.
Rajat Bose of rajatkbose.com advises selling Kaveri Seeds Company and Vesuvius.
Rajat Bose of rajatkbose.com is of the view that Elder Pharmaceuticals may test Rs 121 and Vesuvius India may hit Rs 757-761.
Vesuvius India is a portfolio bet from next two to three years perspective, says Aashish Tater, Head of Research, Fort Share Broking.
Vesuvius India can test Rs 500 in six to eight month time, says SP Tulsian, sptulsian.com.
Accumulate Vesuvius India on every dip. There is limited downside with definite potential upside of 200% from 3-4 years, says Aashish Tater, Head of Research, Fort Share Broking.